Cargando…

Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia

BACKGROUND: Identifying therapeutic targets and prognostic biomarkers significantly contributes to individualized treatment of acute myeloid leukemia (AML). Dihydropyrimidinase‐like 2 (DPYSL2) expression was decreased in homoharringtonine (HHT)‐resistant AML cells, which were established by our grou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fenglin, Ling, Qing, Lian, Jiaying, Chen, Ying, Hu, Chao, Yang, Min, Zhang, Xiang, Li, Chenying, Mao, Shihui, Ye, Wenle, Li, Xia, Lin, Xiangjie, Wei, Wenwen, Huang, Xin, Pan, Jiajia, Qian, Yu, Wang, Jinghan, Lu, Ying, Jin, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134331/ https://www.ncbi.nlm.nih.gov/pubmed/36621846 http://dx.doi.org/10.1002/cam4.5531

Ejemplares similares

Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis
por: Li, Fenglin, et al.
Publicado: (2023)

Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199
por: Mao, Shihui, et al.
Publicado: (2021)

Abivertinib synergistically strengthens the anti‐leukemia activity of venetoclax in acute myeloid leukemia in a BTK‐dependent manner
por: Huang, Shujuan, et al.
Publicado: (2020)

Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia
por: Wei, Wenwen, et al.
Publicado: (2022)

Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study
por: Lin, Xiangjie, et al.
Publicado: (2021)

Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2021)

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3 ‐ITD
por: Qian, Yu, et al.
Publicado: (2023)

Dihydropyrimidinase from Saccharomyces kluyveri can hydrolyse polyamides
por: Quartinello, Felice, et al.
Publicado: (2023)

MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway
por: Ling, Qing, et al.
Publicado: (2021)

Prognostic impact of MYH9 expression on patients with acute myeloid leukemia
por: Yu, Mengxia, et al.
Publicado: (2016)

Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor
por: Li, Ying, et al.
Publicado: (2017)

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2019)

Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2021)

Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2014)

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects
por: Li, Xia, et al.
Publicado: (2018)

Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity
por: Hiratsuka, Masahiro, et al.
Publicado: (2015)

Rational Engineering of the Substrate Specificity of a Thermostable D-Hydantoinase (Dihydropyrimidinase)
por: Aganyants, Hovsep, et al.
Publicado: (2020)

Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites
por: Basbous, Jihane, et al.
Publicado: (2020)

Contribution of the dihydropyrimidinase-like proteins family in synaptic physiology and in neurodevelopmental disorders
por: Desprez, Florence, et al.
Publicado: (2023)

Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer
por: Tsai, Ying-Ming, et al.
Publicado: (2020)

Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma
por: Liang, Peir-In, et al.
Publicado: (2023)

In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase
por: Hishinuma, Eiji, et al.
Publicado: (2020)

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
por: Wang, Jinghan, et al.
Publicado: (2018)

SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia
por: Yue, Can, et al.
Publicado: (2021)

Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia
por: Boyd, Allison L., et al.
Publicado: (2023)

Serum Dihydropyrimidinase-Like 3 Concentration in Patients with Gastric Cancer and Its Diagnostic Value
por: Zhong, Huiqiu, et al.
Publicado: (2021)

Expression of Concern: Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity
Publicado: (2023)

Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance
por: Li, Fenglin, et al.
Publicado: (2022)

Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation
por: Umetsu, Satoko, et al.
Publicado: (2020)

IER3 (IEX‐1) dysregulation serves as a potential prognostic factor in acute myeloid leukemia patients
por: Ke, Shandong, et al.
Publicado: (2021)

The Study of “Dihydropyrimidinase Related Proteins (DRPs)” Expression Changes Influence in Malignant Astrocytoma Brain Tumor
por: Pooladi, Mehdi, et al.
Publicado: (2014)

Structural Basis for pH-Dependent Oligomerization of Dihydropyrimidinase from Pseudomonas aeruginosa PAO1
por: Cheng, Jen-Hao, et al.
Publicado: (2018)

Identification of a novel NPM1 mutation in acute myeloid leukemia
por: Yao, Yiyi, et al.
Publicado: (2023)

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
por: Yao, Yiyi, et al.
Publicado: (2021)

The prognostic relevance and expression of progranulin in adult patients with acute myeloid leukemia
por: Qin, Jiajia, et al.
Publicado: (2020)

Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of Cyclic Amidohydrolases
por: Huang, Cheng-Yang
Publicado: (2015)

Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2017)

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia
por: Zhang, Lidan, et al.
Publicado: (2013)

The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019
por: Yao, Yiyi, et al.
Publicado: (2022)

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia
por: Li, Kongfei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h3a5u5ftcdsk1krj54ouaafsmu